Clinical Trial Update: Immunotherapy for Lymphoproliferative Diseases Associated With Epstein-Barr Virus in Patients Who Have Undergone Organ Transplants [Phase 1]

View source ↗

Summary

A Phase 1 trial of immunotherapy for Epstein-Barr virus–associated lymphoproliferative diseases in organ transplant recipients was withdrawn. The study was spon…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia
• Lymphoma

Snippet

Sponsor: University of Alabama at Birmingham | Conditions: Leukemia, Lymphoma | Phase 1 | Status: WITHDRAWN